Significance of endocrine therapy for unresected primary breast cancer

Kanako Kurata, Masaya Kai, Makoto Kubo, Hitomi Mori, Mai Yamada, Yuji Nakafusa, Masafumi Nakamura

Research output: Contribution to journalArticle

Abstract

At present, surgery is still the recommended principal treatment for breast cancer. However, there are conditions in which surgery is not suitable, for example in elderly or high-risk patients and those who do not wish to undergo the procedure. This study presents a case series of 8 patients with unresected breast cancer who were administered hormonal therapy as an optional treatment. Patients included in the study were diagnosed with Stage I - ID breast cancer from 2012 to 2015 at our institution. The patients were administered hormonal therapy for an average duration of 20.1 months. Complete responses were seen in 4 patients, while 1 and 3 patients were noted to have a partial response and stable disease, respectively. No disease progression was seen in any patients during the study period. Endocrine therapy may be an effective and safe option for patients with unresected breast cancer.

Original languageEnglish
Pages (from-to)1645-1647
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume45
Issue number11
Publication statusPublished - Nov 1 2018

Fingerprint

Breast Neoplasms
Therapeutics
Disease Progression

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Significance of endocrine therapy for unresected primary breast cancer. / Kurata, Kanako; Kai, Masaya; Kubo, Makoto; Mori, Hitomi; Yamada, Mai; Nakafusa, Yuji; Nakamura, Masafumi.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 45, No. 11, 01.11.2018, p. 1645-1647.

Research output: Contribution to journalArticle

Kurata, Kanako ; Kai, Masaya ; Kubo, Makoto ; Mori, Hitomi ; Yamada, Mai ; Nakafusa, Yuji ; Nakamura, Masafumi. / Significance of endocrine therapy for unresected primary breast cancer. In: Japanese Journal of Cancer and Chemotherapy. 2018 ; Vol. 45, No. 11. pp. 1645-1647.
@article{26f1d480d8864720a21b2399f74d84ef,
title = "Significance of endocrine therapy for unresected primary breast cancer",
abstract = "At present, surgery is still the recommended principal treatment for breast cancer. However, there are conditions in which surgery is not suitable, for example in elderly or high-risk patients and those who do not wish to undergo the procedure. This study presents a case series of 8 patients with unresected breast cancer who were administered hormonal therapy as an optional treatment. Patients included in the study were diagnosed with Stage I - ID breast cancer from 2012 to 2015 at our institution. The patients were administered hormonal therapy for an average duration of 20.1 months. Complete responses were seen in 4 patients, while 1 and 3 patients were noted to have a partial response and stable disease, respectively. No disease progression was seen in any patients during the study period. Endocrine therapy may be an effective and safe option for patients with unresected breast cancer.",
author = "Kanako Kurata and Masaya Kai and Makoto Kubo and Hitomi Mori and Mai Yamada and Yuji Nakafusa and Masafumi Nakamura",
year = "2018",
month = "11",
day = "1",
language = "English",
volume = "45",
pages = "1645--1647",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "11",

}

TY - JOUR

T1 - Significance of endocrine therapy for unresected primary breast cancer

AU - Kurata, Kanako

AU - Kai, Masaya

AU - Kubo, Makoto

AU - Mori, Hitomi

AU - Yamada, Mai

AU - Nakafusa, Yuji

AU - Nakamura, Masafumi

PY - 2018/11/1

Y1 - 2018/11/1

N2 - At present, surgery is still the recommended principal treatment for breast cancer. However, there are conditions in which surgery is not suitable, for example in elderly or high-risk patients and those who do not wish to undergo the procedure. This study presents a case series of 8 patients with unresected breast cancer who were administered hormonal therapy as an optional treatment. Patients included in the study were diagnosed with Stage I - ID breast cancer from 2012 to 2015 at our institution. The patients were administered hormonal therapy for an average duration of 20.1 months. Complete responses were seen in 4 patients, while 1 and 3 patients were noted to have a partial response and stable disease, respectively. No disease progression was seen in any patients during the study period. Endocrine therapy may be an effective and safe option for patients with unresected breast cancer.

AB - At present, surgery is still the recommended principal treatment for breast cancer. However, there are conditions in which surgery is not suitable, for example in elderly or high-risk patients and those who do not wish to undergo the procedure. This study presents a case series of 8 patients with unresected breast cancer who were administered hormonal therapy as an optional treatment. Patients included in the study were diagnosed with Stage I - ID breast cancer from 2012 to 2015 at our institution. The patients were administered hormonal therapy for an average duration of 20.1 months. Complete responses were seen in 4 patients, while 1 and 3 patients were noted to have a partial response and stable disease, respectively. No disease progression was seen in any patients during the study period. Endocrine therapy may be an effective and safe option for patients with unresected breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=85056702074&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056702074&partnerID=8YFLogxK

M3 - Article

VL - 45

SP - 1645

EP - 1647

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 11

ER -